Difference between revisions of "Haloperidol"
From Psychiatrienet
(IM -> Long acting) |
|||
| Line 18: | Line 18: | ||
| halflife = 17.5 | | halflife = 17.5 | ||
| halflife_ref = <ref name="pts">{{pts|3791}}</ref><ref name="informatorium" /> | | halflife_ref = <ref name="pts">{{pts|3791}}</ref><ref name="informatorium" /> | ||
| − | | administration = O,IV | + | | administration = O,IM,IV |
| dose = 0.25-15 | | dose = 0.25-15 | ||
| dose_ref = <ref name="informatorium" /> | | dose_ref = <ref name="informatorium" /> | ||
Latest revision as of 11:58, 27 April 2010
| Haloperidol | |||||||||||||||||||
| Type | Antipsychotic | ||||||||||||||||||
| Group | Butyrophenones | ||||||||||||||||||
| links | |||||||||||||||||||
| ATC-code | N05AD01 | ||||||||||||||||||
| Medscape | Haloperidol | ||||||||||||||||||
| PubChem | 3559 | ||||||||||||||||||
| PubMed | Haloperidol | ||||||||||||||||||
| Drugs.com | haloperidol | ||||||||||||||||||
| Kompas (Dutch) | Haloperidol | ||||||||||||||||||
| Wikipedia | Haloperidol | ||||||||||||||||||
| |||||||||||||||||||
Haloperidol is a Antipsychotic in the group Butyrophenones.
- ↑ WHO Collaborating Centre for Drug Statistics Methodology ATC=N05AD01
- ↑ 2.0 2.1 2.2 KNMP; Informatorium Medicamentorum 2023; Monografie "haloperidol" (Dutch)
- ↑ 3.0 3.1 The Lundbeck Institute; Psychotropics; Terminal Plasma Half-lives
- ↑ 4.0 4.1 Farmacotherapeutisch Kompas; Inleidende Tekst Antipsychotica (dutch)
